Cita APA (7a ed.)
Nataraj, R., Dalal, P., Vijayaraghavan, B. K. T., Venkatachalam, P., Kumar, V., Lakshmanan, C., . . . Ranjit, S. (2025). Epinephrine vs Norepinephrine as the Initial Vasoactive Agent in Pediatric Septic Shock: A Feasibility Randomized Controlled Trial for Recruitment Rates and Protocol Adherence, the Epinephrine vs Norepinephrine in Pediatric Septic Shock Trial. Indian Journal of Critical Care Medicine, 29(9), 738-747.
Cita Chicago Style (17a ed.)
Nataraj, Rajeshwari, Parth Dalal, Bharath K. T. Vijayaraghavan, Priyavarthini Venkatachalam, Vasanth Kumar, Chidambaram Lakshmanan, Luregn J. Schlapbach, Niranjan Kissoon, y Suchitra Ranjit. "Epinephrine Vs Norepinephrine as the Initial Vasoactive Agent in Pediatric Septic Shock: A Feasibility Randomized Controlled Trial for Recruitment Rates and Protocol Adherence, the Epinephrine Vs Norepinephrine in Pediatric Septic Shock Trial." Indian Journal of Critical Care Medicine 29, no. 9 (2025): 738-747.
Cita MLA (9a ed.)
Nataraj, Rajeshwari, et al. "Epinephrine Vs Norepinephrine as the Initial Vasoactive Agent in Pediatric Septic Shock: A Feasibility Randomized Controlled Trial for Recruitment Rates and Protocol Adherence, the Epinephrine Vs Norepinephrine in Pediatric Septic Shock Trial." Indian Journal of Critical Care Medicine, vol. 29, no. 9, 2025, pp. 738-747.
Precaución: Estas citas no son 100% exactas.